Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term antiretroviral therapy in adults with early HIV infection
ChiCTR-ONRC-13003483Phase 4Completed
- Sponsor
- China Medical University
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir, lamivudine and efavirenz in human immunodeficiency virus infection (HIV) (2 arms), sponsored by China Medical University. Primary endpoints: CD4 and CD8 T cells and HIV viral load. Started Jan 2012; status: completed.
02
Drugs
tenofovirlamivudineefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ChiCTR-ONRC-13003483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-13003483.